Portfolio Diversification
Range
Most Diversified
30 instruments
January 12, 2022
Least Diversified
20 instruments
January 1, 2022
Average
29.9 instruments
Most Consistent Holdings
Top 5
BIIB100%
REGN100%
SRPT100%
RGEN100%
CRSP100%
Position Sizing
Analysis
Market Exposure
Analysis
Top Sectors
Top 5
Top Countries
Top 5
Holdings over time
(Since January 1, 2022)
| Instrument | Avg. Exposure | Current Exposure | Time Holding | Last Closed |
|---|---|---|---|---|
 Vertex (VRTX) | 3.85% | 3.69% | 99.1% | - |
| Sarepta (SRPT) | 3.67% | 1.09% | 100% | - |
| Regeneron (REGN) | 3.65% | 2.29% | 100% | - |
 Amgen (AMGN) | 3.58% | 3.69% | 99.1% | - |
 Alnylam (ALNY) | 3.54% | 4.3% | 99.1% | - |
 Bristol-Myers Squibb (BMY) | 3.53% | 2.8% | 99.1% | - |
| Repligen (RGEN) | 3.52% | 2.92% | 100% | - |
 Johnson & Johnson (JNJ) | 3.44% | 3.56% | 99.1% | - |
 Jazz Pharmaceuticals (JAZZ) | 3.42% | 2.99% | 99.1% | - |
 Gilead Sciences (GILD) | 3.42% | 3.98% | 99.02% | - |
 IQVIA (IQV) | 3.28% | 2.5% | 99.1% | - |
| CRISPR Therapeutics (CRSP) | 3.27% | 3.19% | 100% | - |
| Biogen (BIIB) | 3.24% | 2.95% | 100% | - |
 Pfizer (PFE) | 3.15% | 2.94% | 99.1% | - |
 Charles River Labs (CRL) | 3% | 2.58% | 99.1% | - |
 Bio-Techne (TECH) | 2.87% | 0% | 86.73% | 12/26/2024 |
 BeiGene (ONC) | 2.6% | 4.8% | 71.25% | - |
 SpringWorks Therapeutics (SWTX) | 2.56% | 4.29% | 71.17% | - |
 Catalent (CTLT) | 2.52% | 0% | 71.74% | 6/26/2024 |
 Agilent (A) | 2.47% | 0% | 72.65% | 12/26/2024 |
 Intellia (NTLA) | 2.47% | 0% | 86.73% | 12/26/2024 |
 United Therapeutics (UTHR) | 2.45% | 2.99% | 70.02% | - |
 Blueprint Medicines (BPMC) | 2.43% | 4.8% | 71.25% | - |
 AstraZeneca (AZN) | 2.4% | 3.69% | 71.25% | - |
 GlaxoSmithKline (GSK) | 2.33% | 4.09% | 69.86% | - |
 Moderna (MRNA) | 2.3% | 0% | 85.83% | 12/26/2024 |
 uniQure (QURE) | 2.3% | 3.27% | 72.07% | - |
 Sanofi (SNY) | 1.98% | 3.48% | 57.17% | - |
 Alkermes (ALKS) | 1.46% | 3.54% | 42.34% | - |
 Ascendis Pharma (ASND) | 1.46% | 4.27% | 42.18% | - |
 BioMarin (BMRN) | 1.28% | 2.81% | 42.34% | - |
 Novartis (NVS) | 1.01% | 0% | 28.5% | 1/4/2024 |
 Verve Therapeutics (VERV) | 0.97% | 3.32% | 28.26% | - |
 Bruker (BRKR) | 0.93% | 0% | 27.85% | 1/9/2023 |
 Revvity (RVTY) | 0.92% | 0% | 27.85% | 1/9/2023 |
 Vir (VIR) | 0.82% | 0% | 27.85% | 1/9/2023 |
 BioNTech SE (BNTX) | 0.75% | 0% | 27.85% | 1/9/2023 |
 Syneos Health Inc (SYNH) | 0.74% | 0% | 27.85% | 1/9/2023 |
 2Seventy Bio (TSVT) | 0.65% | 0% | 27.85% | 1/9/2023 |
 Fate Therapeutics (FATE) | 0.63% | 0% | 28.75% | 1/9/2023 |
 Catalyst Pharmaceuticals (CPRX) | 0.63% | 0% | 14.99% | 12/26/2024 |
 Exelixis (EXEL) | 0.61% | 0% | 14.99% | 12/26/2024 |
 Allogene (ALLO) | 0.51% | 0% | 14.09% | 6/26/2024 |
 Caribou Biosciences (CRBU) | 0.44% | 0% | 14.09% | 6/26/2024 |
 Ionis (IONS) | 0.39% | 3.29% | 13.19% | - |
 Arcturus Therapeutics (ARCT) | 0.38% | 2.46% | 13.27% | - |
 Editas (EDIT) | 0.37% | 0% | 14.99% | 6/26/2024 |
 Twist Bioscience (TWST) | 0.37% | 2.11% | 13.19% | - |
 Pacific Biosciences (PACB) | 0.23% | 0% | 14.99% | 6/26/2024 |
 ProQR (PRQR) | 0.21% | 0% | 27.85% | 1/9/2023 |
 Bayer (BAYN.DE) | 0.05% | 0% | 0.9% | 1/11/2022 |
 Takeda (TAK) | 0.05% | 0% | 0.9% | 1/11/2022 |
 10X Genomics (TXG) | 0.04% | 0% | 0.9% | 1/11/2022 |
 Sangamo (SGMO) | 0.03% | 0% | 0.9% | 1/11/2022 |
 Invitae Corp (NVTAQ) | 0.02% | 0% | 0.9% | 1/11/2022 |
 Cellectis SA (CLLS) | 0.02% | 0% | 0.9% | 1/11/2022 |
 Adverum (ADVM) | 0.01% | 0% | 0.9% | 1/11/2022 |
Exposure over time
Exposure by Sector
Exposure by Country
Portfolio Time Machine
Portfolio date
01
01
2025
| Instrument | Invested | Value |
|---|---|---|
| Arcturus Therapeutics (ARCT) | 3.2% | 3.45% |
| uniQure (QURE) | 1.25% | 3.42% |
| Biogen (BIIB) | 4.45% | 3.41% |
| BeiGene (ONC) | 4.09% | 3.4% |
| Sanofi (SNY) | 3.21% | 3.33% |
| Jazz Pharmaceuticals (JAZZ) | 3.75% | 3.33% |
| Regeneron (REGN) | 3.05% | 3.33% |
| Pfizer (PFE) | 5.32% | 3.33% |
| Charles River Labs (CRL) | 5.14% | 3.32% |
| Sarepta (SRPT) | 2.42% | 3.32% |
| GlaxoSmithKline (GSK) | 3.2% | 3.31% |
| Johnson & Johnson (JNJ) | 3.69% | 3.31% |
| AstraZeneca (AZN) | 3.37% | 3.3% |
| Vertex (VRTX) | 2.05% | 3.3% |
| Amgen (AMGN) | 2.87% | 3.3% |
| BioMarin (BMRN) | 4.27% | 3.29% |
| IQVIA (IQV) | 3.99% | 3.29% |
| Gilead Sciences (GILD) | 2.45% | 3.29% |
| Repligen (RGEN) | 4.1% | 3.28% |
| Ascendis Pharma (ASND) | 3.2% | 3.27% |
| SpringWorks Therapeutics (SWTX) | 2.39% | 3.27% |
| Bristol-Myers Squibb (BMY) | 3.51% | 3.27% |
| United Therapeutics (UTHR) | 3.2% | 3.25% |
| Alkermes (ALKS) | 3.09% | 3.24% |
| Alnylam (ALNY) | 2.16% | 3.24% |
| Verve Therapeutics (VERV) | 2.8% | 3.23% |
| Blueprint Medicines (BPMC) | 1.95% | 3.23% |
| CRISPR Therapeutics (CRSP) | 4.42% | 3.22% |
| Ionis (IONS) | 3.2% | 3.22% |
| Twist Bioscience (TWST) | 3.2% | 3.19% |